158 related articles for article (PubMed ID: 27067684)
1. [Outcome and Problems of Nab-Paclitaxel Therapy for Gastric Cancer in Clinical Practice].
Doi T; Ishikawa T; Okayama T; Dohi O; Yoshida N; Kamada K; Katada K; Sogame Y; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Naito Y; Itoh Y
Gan To Kagaku Ryoho; 2016 Feb; 43(2):211-4. PubMed ID: 27067684
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302).
Tamura S; Taniguchi H; Nishikawa K; Imamura H; Fujita J; Takeno A; Matsuyama J; Kimura Y; Kawada J; Hirao M; Hirota M; Fujitani K; Kurokawa Y; Sakai D; Kawakami H; Shimokawa T; Satoh T
Int J Clin Oncol; 2020 Dec; 25(12):2035-2043. PubMed ID: 32926227
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.
Sasaki Y; Nishina T; Yasui H; Goto M; Muro K; Tsuji A; Koizumi W; Toh Y; Hara T; Miyata Y
Cancer Sci; 2014 Jul; 105(7):812-7. PubMed ID: 24716542
[TBL] [Abstract][Full Text] [Related]
4. Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
Kanazawa Y; Fujita I; Kakinuma D; Arai H; Matsuno K; Shimoda T; Ko K; Kato S; Uchida E
Anticancer Res; 2017 May; 37(5):2715-2720. PubMed ID: 28476850
[TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
[TBL] [Abstract][Full Text] [Related]
6. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].
Ouchi A; Ouchi A; Asano M; Aono K; Watanabe T; Kato T
Gan To Kagaku Ryoho; 2014 Jul; 41(7):889-91. PubMed ID: 25131878
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
Takashima A; Shitara K; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Fujii H; Muro K; Esaki T; Choda Y; Takano T; Chin K; Sato A; Goto M; Fukushima N; Hara T; Machida N; Ohta M; Boku N; Shimura M; Morita S; Koizumi W
Gastric Cancer; 2019 Jan; 22(1):155-163. PubMed ID: 29855738
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer.
Fukuchi M; Mochiki E; Ishiguro T; Ogura T; Sobajima J; Kumagai Y; Ishibashi K; Ishida H
Anticancer Res; 2016 Dec; 36(12):6699-6703. PubMed ID: 27920005
[TBL] [Abstract][Full Text] [Related]
9. [Nanoparticle albumin-bound Paclitaxel for unresectable or recurrent gastric cancer].
Egawa T; Kemmochi T; Nishiya S; Mihara K; Ito Y; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2251-3. PubMed ID: 25731486
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience of nab-Paclitaxel treatment in 31 patients with breast cancer].
Tauchi Y; Kashiwagi S; Ishihara S; Asano Y; Sakimura C; Kurata K; Tokumoto M; Morisaki T; Noda S; Kawajiri H; Takashima T; Onoda N; Hirakawa K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1948-50. PubMed ID: 25731385
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.
Saxena A; Schneider BJ; Christos PJ; Audibert LF; Cagney JM; Scheff RJ
Med Oncol; 2016 Feb; 33(2):13. PubMed ID: 26749586
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications.
Kudlowitz D; Muggia F
Expert Opin Drug Saf; 2014 Jun; 13(6):681-5. PubMed ID: 24749649
[No Abstract] [Full Text] [Related]
14. [Efficacy of supportive care for albumin-bound paclitaxel(nab-paclitaxel)in 20 patients with metastatic breast cancer].
Yamada C; Yonezawa M; Shimizu Y; Taga R; Kashihara H; Tsuji K; Murata T; Yoshino H
Gan To Kagaku Ryoho; 2014 Jan; 41(1):77-81. PubMed ID: 24423956
[TBL] [Abstract][Full Text] [Related]
15. Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.
Fabi A; Giannarelli D; Malaguti P; Ferretti G; Vari S; Papaldo P; Nisticò C; Caterino M; De Vita R; Mottolese M; Iacorossi L; Cognetti F
Drug Des Devel Ther; 2015; 9():6177-83. PubMed ID: 26640370
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima T; Kawajiri H; Nishimori T; Tei S; Nishimura S; Yamagata S; Tokunaga S; Mizuyama Y; Sunami T; Tezuka K; Ikeda K; Ogawa Y; Kashiwagi S; Noda S; Onoda N; Ishikawa T; Kudoh S; Takada M; Hirakawa K; Ohira M
Anticancer Res; 2018 Jan; 38(1):379-383. PubMed ID: 29277798
[TBL] [Abstract][Full Text] [Related]
17. Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases.
Xie Y; Gong C; Zhang J; Wang L; Cao J; Tao Z; Li T; Zhao Y; Li Y; Hu S; Wang B; Hu X
BMC Cancer; 2021 Nov; 21(1):1174. PubMed ID: 34727875
[TBL] [Abstract][Full Text] [Related]
18. Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.
Langer CJ; Hirsh V; Okamoto I; Lin FJ; Wan Y; Whiting S; Ong TJ; Renschler MF; Botteman MF
Br J Cancer; 2015 Jun; 113(1):20-9. PubMed ID: 26035702
[TBL] [Abstract][Full Text] [Related]
19. [Complete Remission after Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Non-Small-Cell Lung Cancer].
Sugiura Y; Hashizume T; Kawai O; Ohkubo Y; Fusegawa H; Araki N; Kaseda S; Nemoto E
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1095-7. PubMed ID: 26469167
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Taxane-Pretreated Metastatic Gastric Cancer with Excellent Response to Nab-Paclitaxel].
Kawabata R; Kimura Y; Kawase T; Yoshikawa M; Kameda C; Matsumura T; Koga C; Murakami M; Hirota M; Noura S; Ikenaga M; Shimizu J; Hasegawa J
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2088-90. PubMed ID: 26805273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
